BSTC Financial Facts
Diluted net income (loss) per share: 0.42Total Cost and Expenses: 2.16M
See Full Income Statement
Income tax receivable: 0
Additional paid-in capital: 32.65M
See Full Balance Sheet
BioSpecifics Technologies Corp. (BSTC) Earnings
|
Expand Research on BSTC
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -0.2% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
3/14/16 | Q416 | $0.36 | N/A | N/A | $6.1M | $4.6M | N/A | Details | |||
5/10/16 | Q116 | $0.40 | $0.37 | +$0.03 | $6.6M | $6.25M | N/A | Details | |||
11/10/14 | Q314 | $0.21 | $0.19 | +$0.02 | $4M | $4M | N/A | Details | |||
8/9/16 | Q216 | $0.37 | $0.35 | +$0.02 | $6.2M | $6.25M | N/A | Details | |||
8/11/14 | Q214 | $0.09 | $0.12 | -$0.03 | $2.7M | $2.91M | N/A | Details | |||
5/11/15 | Q414 | $0.32 | N/A | N/A | $5.6M | $2.3M | N/A | Details | |||
11/9/15 | Q315 | $0.39 | N/A | N/A | $6.3M | $7.51M | N/A | Details | |||
8/10/15 | Q215 | $0.24 | N/A | N/A | $4.7M | $2.6M | N/A | Details |